HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Greater Claims Leeway Proposed By Health Freedom Protection Act

This article was originally published in The Tan Sheet

Executive Summary

A bill introduced in Congress Nov. 9 would "prevent FDA from disallowing structure function claims that include terms that refer to signs or symptoms of disease so long as the disease itself is not mentioned.

You may also be interested in...



Health Freedom Protection Act, take two

Ron Paul, R-Texas, and others reintroduced the Health Freedom Protection Act, H.R. 2117, May 1. Paul first introduced the bill in November 2005 (1"The Tan Sheet" Nov. 14, 2005, p. 10). The bill seeks to amend the Food, Drug and Cosmetic Act to allow broader dietary supplement claims, even venturing into the drug arena. The bill also seeks a more rapid response to health claims - after 100 days if there is no response from the HHS secretary the claims would be allowed. The legislation also proposes FTC must notify advertisers before the agency conducts an investigation and give 30 days for companies to discontinue their ads...

Emord, Liberty Caucus Back “Comprehensive” Health Claim Reform Bill

FDA would be prohibited from "taking any action" to impede the distribution of scientific literature on nutrient-disease relationships under legislation being drafted with the support of a libertarian caucus group

Energizer Grows Personal Care With Acquisition Of Leading Sun-Care Brands

Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS126677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel